Ingenia Therapeutics Inc. (KOSDAQ:950260)
23,200
+3,000 (14.85%)
At close: Nov 18, 2026
| Market Cap | 1.15T |
| Revenue (ttm) | 7.42B |
| Net Income | -22.38B |
| EPS | -807.42 |
| Shares Out | 49.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 780,129 |
| Open | 20,200 |
| Previous Close | 20,200 |
| Day's Range | 19,710 - 23,300 |
| 52-Week Range | 9,900 - 29,950 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 19, 2026 |